Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Journey Medical CorpDERM · Entity 6273 | Director | July 01, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Journey Medical Corp
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 231,618 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 50,000 · Balance 231,618 F1: On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031. F2: Includes restricted stock units, which vest over various time periods. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031.
F2: Includes restricted stock units, which vest over various time periods.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 2, 2026 20:06 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-080317 · tm2619538-2_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,618 F1 · shares: On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 20:20 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-078286 · tm2619089-5_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,618 F1 · shares: On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 21:17 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-075270 · tm2522819-4_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,618 F1 · shares: On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| June 25, 2025 Filed Jul 8, 2025 01:47 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 7,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-066237 · tm2520050-2_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,618 F1 · shares: On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 20:45 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, $0.0001 par value | 9,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-078973 · tm2419199-4_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,445 F1 · shares: On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025. F2 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:02 UTC | Journey Medical Corp DERM · Entity 6273 | PurchaseCommon Stock, $0.0001 par value | 30,000 | $3.47 | $104,100.00 |
DisclosureSEC source: 0001104659-24-038433 · tm249705-2_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,717 F1 · balance_after: Includes restricted stock units, which vest over various time periods. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 20:01 UTC | Journey Medical Corp DERM · Entity 6273 | PurchaseCommon Stock, par value $0.0001 per share | 33,000 | $2.98 | $98,340.00 |
DisclosureSEC source: 0001104659-23-109604 · tm2328591-1_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,717 F1 · price: Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 13, 2023, was $2.80 to $3.00. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 20:06 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, par value $0.0001 per share | 27,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-083833 · tm2321950-3_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,717 F1 · shares: On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024. F2 · balance_after: Includes 61,717 restricted stock units, 27,472 units of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 of which will vest on July 1, 2024. Read SEC document |
| July 21, 2022 Filed Jul 25, 2022 13:39 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCommon Stock, par value $0.0001 per share | 14,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-082290 · tm2221508-6_4seq1.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,245 F1 · shares: On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023. F2 · balance_after: Includes 34,245 restricted stock units, 14,245 of which will vest as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024. Read SEC document |
| January 14, 2022 Filed Apr 4, 2022 20:48 UTC | Journey Medical Corp DERM · Entity 6273 | GrantCOMMON STOCK | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042279 · tm2211324-9_4.xml · nonDerivative · entry 1 Smith Justin Adam · CIK 0001894583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · shares: The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024. F2 · balance_after: Includes restricted stock units, which vest over various time periods as set forth in footnote 1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.